National Black Church Initiative Pushes to Close Racial Gaps in Clinical Trials
The National Black Church Initiative is working to increase African American and Latino participation in clinical trials, addressing long-standing racial disparities in medical research. The organization is partnering with healthcare institutions to recruit participants from Black congregations across the country. Leaders say the effort is critical because many treatments are tested primarily on white patients, leaving minority communities with less data on how drugs affect them.
The National Black Church Initiative is running a campaign to increase African American and Latino participation in clinical trials, targeting a gap that health advocates say has persisted for decades.
The NBCI, which represents more than 34,000 churches and 15 million African Americans, is partnering with healthcare institutions to recruit trial participants from Black congregations. The organization argues that medical research has historically underrepresented minority communities, leaving doctors with limited data on how treatments affect Black patients.
Clinical trial diversity has become a more prominent issue in recent years. The FDA issued guidance in 2022 encouraging drug developers to enroll more diverse participants, but advocates say voluntary measures have not been enough.
The NBCI's approach uses the trust that Black churches have built in their communities to connect congregants with research opportunities. Church leaders are trained to explain what clinical trials involve and to address common concerns about participation, including historical abuses like the Tuskegee syphilis study.
The initiative is also focused on healthcare equity more broadly, including access to mental health services and preventive care. In cities like Detroit, church leaders have expanded outreach to address community stress and anxiety, and to advocate for better education and healthcare access.
NBCI President Anthony Evans said the church is uniquely positioned to reach people who distrust the medical system. He said building that trust requires consistent presence in communities, not just outreach during health crises.
